Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis B news

Show

From To
China progresses in hepatitis B vaccination, more treatment effort urged

China has won praises from WHO after reaching its goal to control hepatitis B infection among children through immunization ahead of schedule, but more effort is urged for its adult patients.

Published
27 July 2015
From
Xinhua
Access to screening and treatment are key issues for hepatitis B and C and HIV/viral hepatitis co-infection

The development of effective new interferon-free treatment makes it possible to cure more than 90% of people with chronic hepatitis C, including most people with HIV and hepatitis

Published
20 July 2015
By
Liz Highleyman
Drug Resistance Common Among European Patients With Chronic Hepatitis B

Rates of lamivudine resistance are high among patients with chronic hepatitis B (CHB) infection across Europe, with many patients developing cross-resistance to entecavir, according to a new report.

Published
14 July 2015
From
Medscape
Hepatitis B and C co-infection linked to worse liver fibrosis than hepatitis B alone

People with both hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infection may experience more rapid and severe liver disease progression than those with hepatitis B

Published
08 June 2015
By
Liz Highleyman
Hepatitis B and C - An Action Plan for Saving Lives in Europe

Last year, leading experts, institutions, patient organisations and pharmaceutical industry representatives met and agreed that the major recommendations produced between 2011 and 2014 should be compiled into one comprehensive document, to make it easier for policy makers, decision makers, civil society organisations and healthcare institutions to tackle viral hepatitis effectively.

Published
20 May 2015
From
European Liver Patients Association
Starved T cells allow hepatitis B to silently infect liver

Hepatitis B stimulates processes that deprive the body’s immune cells of key nutrients that they need to function, finds new UCL-led research funded by the Medical Research Council and Wellcome Trust. The work helps to explain why the immune system cannot control hepatitis B virus infection once it becomes established in the liver, and offers a target for potential curative treatments down the line.

Published
14 May 2015
From
University College London press release
Expanded vaccination and treatment could help eliminate hepatitis B worldwide

While universal infant hepatitis B virus (HBV) vaccination has already led to major advances in reducing new infections in some settings, further expansion of prevention and treatment

Published
25 April 2015
By
Liz Highleyman
Cancer drug shows promise as cure for hepatitis B

A potential cure for hepatitis B virus infections has been found with a promising new treatment proving 100 per cent successful in eliminating the infection in preclinical models. Australian patients are now the first in the world to have access to the potential treatment -- a combination of an antiviral drug and an anti-cancer drug -- which is in phase 1/2a clinical trials.

Published
21 April 2015
From
Science Daily
Arrowhead initiates phase 2b trial for potential HBV drug

After receiving a clinical hold from the FDA earlier this year, Arrowhead Research Corporation has now been approved by the FDA to begin a multiple-dose phase 2b clinical study of ARC-520 for the treatment of chronic hepatitis B infection, according to a news release from the drug maker.

Published
14 April 2015
From
Healio Hepatology
Global hepatitis B epidemic treatable at cost of just $36 per patient per year

Large-scale production of generic entecavir could cut the cost of first-line hepatitis B virus (HBV) therapy to just US$36 per patient per year, according to a study published

Published
08 April 2015
By
Michael Carter
← First12345...13Next →

Filter by country